Just two days to go! Oxford’s annual Health Research Showcase takes place on Thurs 28th @WestgateOxford between 10am & 3.30pm
Come along and find out about the latest in healthcare research, and have fun at the same time! @OxHealthBRC@OxfordMedSci
EVENT: Health research showcase
Organised by NIHR BRC: Oxford and @OxHealthBRC, this is an opportunity to enjoy hands-on activities while learning about the latest ground-breaking research taking place in Oxford.
Thur 28 May
https://t.co/L7TJU4HT8w
Next month is a research highlight of the year – the Health Research Showcase @WestgateOxford. Come on 28/5 & meet enthusiastic researchers, do fun activities & learn about the latest research taking place in Oxford https://t.co/7VjAM5A1p8 @OxHealthBRC@NIHRresearch@OUHospitals
A research study by Oxford neurosurgeons and engineers is trialling whether deep brain stimulation (DBS) – delivering an electrical pulse into affected areas of the brain – can help to relieve central post-stroke pain (CPSP).
Read more ➡️ https://t.co/yuuipZOt2a
This fascinating talk is taking place this evening!
Can deep brain stimulation treat chronic pain - and other neurological conditions?
It's free. Just turn up, no need to book. Refreshments from 5.30pm
@OxHealthBRC@OUHospitals@OxfordHealthNHS@OxfordMedSci@NDSurgicalSci
A reminder that on Thursday 12th there’s a fascinating FREE public talk on whether deep brain stimulation – inserting electrodes into the brain - can help to tackle chronic pain. Come along to Rewley House in central Oxford
https://t.co/trCP6sY4Js
@OUHospitals@OxfordHealthNHS
A reminder that on Thursday 12th there’s a fascinating FREE public talk on whether deep brain stimulation – inserting electrodes into the brain - can help to tackle chronic pain. Come along to Rewley House in central Oxford
https://t.co/trCP6sY4Js
@OUHospitals@OxfordHealthNHS
A new state-of-the-art high-intensity focused ultrasound (HIFU) machine has been installed at the Churchill Hospital, giving Oxford University Hospitals (OUH) cancer patients access to the latest in this innovative technology.
Read more ➡️ https://t.co/A8mg5nSXCD
A new state-of-the-art high-intensity focused ultrasound #HIFU machine has been unveiled at our Churchill Hospital, giving our cancer patients access to this emerging technology.
https://t.co/eguDAUpAwh
@NDSurgicalSci@FUSFoundation
A new clinical study is exploring whether advanced MRI scanning of kidneys before and after transplantation could provide a non-invasive, objective way to evaluate donor organs and monitor transplant health.
Read more ➡️https://t.co/WVZKcn53wR
Surgery for a common elbow fracture in children offers no clinical benefit compared to non-surgical care, researchers @ndorms & @AlderHeyRes have found. The findings could have big implications for treatment and cost savings for the NHS https://t.co/fdpVYHFtpD @NIHRresearch
Study suggests that women who develop high #BloodPressure during pregnancy may be able to protect their long‑term brain health with better BP management soon after birth https://t.co/sD10PAl27H @RDMOxford@NIHRresearch
NEWS: Night-time changes in metabolism may be driving common liver disease
Researchers at @UniofOxford have discovered that the most common liver disease follows a strong day-night pattern, and the metabolic changes are most pronounced overnight.
https://t.co/UsQA7VoJFx
NEWS: @NIHRresearch Oxford Senior Research Fellows named
Congratulations to those appointed to be among the next cohort of NIHR Oxford Senior Research Fellows, including several @OxfordMedSci mid-career researchers.
https://t.co/u7ejEeiYoJ
New study from @NIHRresearch Oxford BRC:
Are night-time metabolic changes driving the most common liver disease? Researchers found the metabolic changes that drive #MASLD happen overnight, when the body is least able to process sugar and fat #NAFLD 1/4
https://t.co/xhg8zxGHm2
Lead author Tom Marjot says the findings offer exciting opportunities to help treat #MASLD, including optimising the timing of meals and exercise and informing when to take medication. 3/4
First patient treated @ouhospitals in second phase of clinical trial testing new gene therapy for inherited eye condition #Stargardt disease, which leads to vision loss & blindness in children & adults https://t.co/bRhzWt8NLq
@NDCNOxford@NIHRresearch@SpliceBioHQ@eyeMacLaren